The sequence of events downstream of CaSR activation that actually link CaSR to cell cycle control in colon carcinoma cells starts with inhibition of phospholipase A2 activity [135] (Figure 1 and Figure 3), which would reduce the amount of arachidonic acid available for the synthesis of proliferation-stimulating prostaglandins. This evidence concerns the gene CASR and colon carcinoma.